Suboxone vs Methadone

Suboxone and methadone are the two leading medications for opioid addiction, and both work well. They differ mainly in overdose safety and access: Suboxone comes from a regular doctor's office, while methadone means a daily clinic visit.

Jessica Miller is the Content Manager of Addiction HelpWritten by
Kent S. Hoffman, D.O. is a founder of Addiction HelpMedically reviewed by Kent S. Hoffman, D.O.
Last updated

Battling addiction & ready for help?

Find Treatment Now

Suboxone vs Methadone, Two Proven Ways Out Side by Side

If you or someone you love is choosing between Suboxone and methadone, start here. These are the two most effective medicines we have for opioid addiction, each one is tied to about half the risk of dying, and choosing either is real recovery — not “trading one addiction for another.” One isn’t the strong choice and the other the weak one. They suit different lives, and the best medicine is simply the one you can start and stay on.

Suboxone (buprenorphine with naloxone) and methadone work in different ways and come with different rules. Methadone tends to keep more people in treatment, especially those with the longest, heaviest histories. Suboxone is far safer in an overdose, and you can get it from a regular doctor instead of a daily clinic. Both quiet cravings, lift withdrawal, and let people get back to work, family, and a normal life. What follows lays the two out evenly, so you can have a real conversation with a prescriber about which one fits you.

AddictionHelp.com Fast Facts
  • Both cut the risk of dying by roughly half. Staying on either medicine is tied to about half the death risk of no treatment, and head-to-head they are similar on overall survival[1].
  • Methadone holds more people in treatment; Suboxone is safer and easier to get. Methadone’s retention edge matters most in severe addiction, while Suboxone rarely causes a fatal overdose and can come from a regular doctor or telehealth[1][2].
  • Neither is “still using.” Being steady on a prescribed dose treats a medical condition, and staying on longer protects recovery better than a fast taper[3].

A quick safety note before the details. If you or someone you love is in crisis right now, you do not have to wait for an appointment. Call or text 988 any time, or call SAMHSA at 1-800-662-HELP (4357), a free and confidential line that can connect you to a buprenorphine prescriber or a methadone clinic near you. If anyone around you uses opioids, keep naloxone (Narcan) on hand — it reverses an overdose within minutes.

How Suboxone and Methadone Compare at a Glance

The summary is that these two medicines trade strengths. Methadone leans toward keeping people in treatment. Suboxone leans toward safety and access. Here is the head-to-head, and the sections below cover each row.

Suboxone (buprenorphine/naloxone) Methadone
How it acts Partial opioid agonist with a built-in ceiling[4] Full opioid agonist[4]
Cuts the risk of dying Yes — tied to roughly half the risk[1] Yes — tied to roughly half the risk[1]
Keeps people in treatment Strong, but somewhat lower than methadone[1] Highest retention, especially in severe cases[5]
Overdose safety Safer — the ceiling makes a fatal overdose on it alone rare Narrower margin; the dose is raised slowly and carefully early on
Where you get it A regular doctor’s office or telehealth, filled at a pharmacy[2] Licensed clinics only, often daily visits at first[6]
Daily routine A film or tablet under the tongue at home A daily dose, usually liquid, watched at the clinic early on[6]
Starting catch Wait until withdrawal clearly begins, or it can briefly worsen[7] Builds up over days, so it is started low and raised slowly
Strongest fit Lower-severity addiction, strong support, or no clinic nearby Long heavy histories, fentanyl, treatment that did not hold before

Switching is always possible. Starting on one does not lock you out of the other, and the right medicine can change as life changes.

How Each Medicine Works in the Body

Both medicines act on the same brain receptors as heroin, fentanyl, and prescription painkillers — but they do it in very different ways, and that difference shapes everything else, including how safe each one is.

Methadone Switches the Receptors Fully On

Methadone is a full mu-opioid agonist. It turns those receptors all the way on, the same as other opioids, but because it is swallowed and absorbed slowly, it does not produce the rush of an injected or smoked drug. At a steady dose, a person on methadone does not feel high — they feel normal. Its long action, 24 to 36 hours or more, is what makes once-daily dosing work and what smooths out the peaks and crashes that drive continued use.

Dose matters a great deal. In a controlled study, 120 mg of methadone fully suppressed withdrawal and blocked heroin’s effects, while 30 mg and 60 mg eased withdrawal but did not fully block other opioids[4]. That is the pharmacological reason underdosing fails: it leaves the door to other opioids open.

Suboxone Switches Them Only Partway

The buprenorphine in Suboxone is a partial agonist. It turns the same receptors partway on and then stops, no matter how much more is taken — and that ceiling is the whole reason it is safer. Past a certain dose, buprenorphine stops slowing your breathing, so on its own it rarely causes a fatal overdose in an adult[4]. It also grips the receptor tightly and lets go slowly, so once it is on board, using other opioids on top of it often “does nothing.” That blocking effect is part of what keeps people safe.

The naloxone in Suboxone confuses people, so it is worth being plain. Taken under the tongue as prescribed, the naloxone is inactive — it is absorbed so poorly that the buprenorphine does all the work[8]. It is there only to discourage injection: if someone tries to dissolve and shoot the film, the naloxone becomes active and triggers sharp withdrawal. Studies confirm people are far less likely to inject the combination than buprenorphine alone[9]. If you cannot tolerate it, plain buprenorphine without naloxone exists too, and a prescriber can walk you through how buprenorphine works.

Did you know?

After a nonfatal overdose, the single most protective thing a person can do is start one of these medicines. People who began methadone or buprenorphine after an overdose had markedly lower odds of dying in the following year than those who got no medication at all[10].

What the Evidence Shows About Effectiveness

Both medicines have decades of research behind them, and the most important finding is the one they share. Compared with no medication, treatment with either methadone or buprenorphine is tied to about half the risk of death, including death from overdose[1]. That is the number that matters most, and on overall survival the two are broadly similar.

Where they differ is retention — staying in treatment long enough for recovery to take hold. The large head-to-head review found methadone keeps somewhat more people in treatment than buprenorphine, particularly at the start and among those with the heaviest use[1]. A 2025 analysis of seven randomized trials reached the same conclusion, with methadone outperforming buprenorphine-naloxone on six-month retention[5]. That edge is methadone’s strongest argument, because a medicine only protects you while you are still taking it. Both also sharply cut street-opioid use: methadone reduces heroin use by roughly two-thirds compared with no medication[11].

Suboxone’s counterweight is safety and reach. Because buprenorphine has a ceiling, it is far harder to overdose on, and because a regular clinician can prescribe it, it reaches people who could never make a daily clinic work[2]. Office-based buprenorphine can hold people for years — one family-medicine practice kept 47% of patients in treatment at three years[12]. For many people the medicine that wins is simply the one they can start today and keep taking, and the length of time on either one is what predicts staying off street opioids[3].

Methadone Offers the Strongest Hold With More Structure

Methadone has the longest track record of any opioid addiction medicine, and its great strength is keeping people engaged.

Why Methadone Keeps More People in Treatment

The whole point of treatment is to stay in it long enough to rebuild a life, and methadone’s retention edge is real and measurable[1]. As a full agonist it fully covers high opioid tolerance, which is exactly what people with long fentanyl or heroin histories often need. Dose is the lever: most adults do best at 60 to 120 mg a day, and reaching an adequate dose early matters. Patients who got to at least 70 mg by day seven had 91% thirty-day retention, versus 80% for those kept under 30 mg[13]. Underdosing, not the medicine itself, is a leading reason treatment fails.

What the Clinic Schedule Actually Demands

In the United States, methadone for addiction is dispensed only through licensed clinics, and early on that usually means showing up every day for an observed dose.

The structure keeps the start safe, but it is a genuine burden:

  • Patients spend an average of 75 minutes and about $37 per visit[6]
  • Nearly 92% want more take-home doses[6]
  • Two-thirds say the clinic schedule strains their ability to work[6]
  • Whole regions of the country have few clinics, so access is uneven[2]

It eases with time. As people prove stability, they earn take-home doses, and rules loosened during the pandemic became permanent in 2024 — at one program, letting people take more doses home cut dropout from 27% to 16%[14]. Cost shapes who stays, too: patients given methadone for free were nearly four times as likely to still be in treatment at six months as those paying out of pocket[15].

The Heart-Rhythm Point Worth Knowing

Methadone carries one extra thing prescribers watch that most opioids do not. At higher doses it can stretch the heart’s electrical rhythm (the QT interval), and in rare cases that can trigger a dangerous arrhythmia. One study of people on methadone maintenance found QT prolongation in 38%[16]. The practical answer is not to avoid methadone but to assess risk — a baseline heart tracing for anyone with cardiac risk factors, and caution mixing it with other sedatives. Benzodiazepines turned up in roughly four out of five methadone overdose deaths[17], which is why combining methadone with Xanax, alcohol, or sleep medication is so dangerous.

Suboxone Is the Safer, More Reachable Option

Buprenorphine reshaped opioid treatment by moving it out of the clinic and into ordinary medical care, and its built-in ceiling makes it forgiving.

Why Suboxone Is Harder to Overdose On

Because buprenorphine only switches the receptors partway on, adding more past a point stops adding risk to your breathing — the single biggest reason it is safer than a full agonist in an overdose[4]. That same ceiling means the right dose matters: most people need 16 to 24 mg a day, and the common starting dose of 8 mg often leaves cravings unaddressed, which is a dosing problem, not a willpower one[18].

You Can Get It From a Regular Doctor

Since 2023, any clinician who can prescribe controlled substances can prescribe buprenorphine from an ordinary office or by telehealth, filled at a normal pharmacy[19]. For someone with a job, a family, transportation barriers, or no clinic nearby, that access can be the difference between getting treated and not. Counseling helps but is not a gate: adding required therapy to buprenorphine did not improve the odds of staying opioid-free in a recent analysis[20], so a lack of available counseling should never keep anyone off the medicine.

The One Real Catch Is Timing the First Dose

Suboxone’s main pitfall is at the very start. Taken while other opioids are still active, it can briefly make withdrawal worse (called precipitated withdrawal), which is why the rule is to wait until withdrawal clearly begins. That fear has been overblown: across studies the rate runs from 0% to about 13%, and researchers concluded it “should not be a barrier to use”[7]. In the fentanyl era, newer low-dose starts make this even more manageable, and a prescriber will time the first dose with you.

Did you know?

The naloxone in Suboxone is essentially a passenger when taken correctly — but in one situation it is not. In severe liver disease, naloxone levels in the body can climb to about 14 times the normal amount, so the plain buprenorphine version is the better choice for those patients[21]. It is a good example of why the medicine should be matched to the person.

Which Is Right for You

There is no universally “right” answer between Suboxone and methadone — only the right fit for a particular person at a particular moment. A few honest questions usually point the way.

  • How severe and how long? Long, heavy histories, high fentanyl tolerance, or treatment that did not hold before tend to favor methadone’s stronger retention[5].
  • What can you actually get to? No clinic nearby, a demanding job, or caregiving at home tend to favor Suboxone’s office and telehealth access[2].
  • What does your daily life allow? Daily observed dosing can be steadying structure for one person and an impossible burden for another[6].
  • Any health flags? Heart-rhythm concerns may push toward Suboxone; a need for full opioid coverage may push toward methadone[16].

The worst choice is no medicine at all. If you want the safest, most reachable option and your addiction is not at the most severe end, Suboxone is a strong place to start. If you have a long history, fentanyl in the mix, or treatment that has not held, methadone’s retention edge may serve you better. Either way, you are not locked in — many people move between the two as their lives change, and what predicts staying off opioids is the time spent on treatment, not which one came first[3].

One belief deserves to be named and put to rest. Being steady on a prescribed dose of either medicine is not “still using,” and it is not swapping one addiction for another. Addiction is compulsive, life-wrecking, out-of-control use; these medicines do the opposite, quieting cravings and withdrawal so a person can rebuild[3]. Staying on treatment longer protects recovery better than rushing to taper off. If a long-acting injection or the no-opioid option fits you better, naltrexone is worth asking about too.

Getting Started on Either One

You do not have to figure this out alone, and you do not have to white-knuckle anything. A prescriber can walk you through both, start you on whichever fits, and adjust as you go — the way out is far less brutal, and far more reachable, than the fear makes it look.

If you want to read more about each medicine on its own, see how buprenorphine works and how methadone works. If you are coming off heroin or pills, heroin addiction and prescription opioids walk through what recovery looks like from there.

Whenever you are ready to take the first real step, free and confidential help is waiting. Get matched with treatment that fits your life →

If any of this lands, the next step doesn’t have to be a big one. You can find treatment now and get matched with someone who can help you find the right care and take the next step. Reaching out today is a real step forward — and one you can make right now.

Frequently asked questions

Which is better, Suboxone or methadone?

Neither is simply better, they trade strengths. Both cut the risk of dying by roughly half and both are real recovery[1]. Methadone tends to keep more people in treatment, which matters most for long, heavy histories, while Suboxone is far safer in an overdose and far easier to get from a regular doctor[2]. The best medicine is the one you can start and stay on, and a prescriber can help you match it to your life.

Is being on Suboxone or methadone just trading one addiction for another?

No. Being steady on a prescribed dose is physical dependence, not addiction. Addiction is the compulsive, out-of-control use that wrecks your life; these medicines do the opposite by quieting cravings and withdrawal so you can rebuild work, family, and health. People who stay on treatment longer hold onto recovery far better than those who taper off early[3]. It is medicine for a medical condition, much like treatment for blood pressure or diabetes.

Why is methadone only at a clinic when Suboxone is at a regular doctor?

It is a regulatory difference, not a measure of how well each works. Methadone for addiction is dispensed only through federally licensed clinics, usually with daily observed dosing at first, which keeps the start safe but is a real burden and is unevenly available across the country[2]. Buprenorphine (Suboxone) can be prescribed from an ordinary office or by telehealth since 2023 and filled at a normal pharmacy[19]. As people prove stability on methadone, they earn take-home doses[6].

Which one is safer in an overdose?

Suboxone. The buprenorphine in it is a partial agonist with a built-in ceiling, so past a certain dose it stops slowing your breathing, which makes a fatal overdose on it alone rare in an adult. Methadone is a full agonist with a narrower safety margin, especially while the dose is being raised early in treatment, which is part of why it is started low and supervised[4]. Both, taken as prescribed, are far safer than continued street-opioid use.

What does the naloxone in Suboxone do?

When you take Suboxone under the tongue as directed, the naloxone is absorbed so poorly that it does essentially nothing, and the buprenorphine does all the work[8]. It is added only to discourage misuse: if someone tries to inject the film, the naloxone becomes active and triggers sharp withdrawal, and studies show people are far less likely to inject the combination than buprenorphine alone[9]. If the combination does not suit you, plain buprenorphine without naloxone is also available.

Can I switch from one to the other later?

Yes. Starting on one does not lock you out of the other, and the right medicine can change as your life and needs change. People sometimes move from methadone to Suboxone for the convenience, or from Suboxone to methadone when they need methadone’s stronger retention, and what predicts staying off street opioids is the length of time on either medicine, not which one you picked first[3]. A prescriber can plan a safe switch and time it so you do not go through unnecessary withdrawal.

Get Treatment Help

If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.

Exclusive offer: 20% Off BetterHelp*

Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

21 Sources
  1. Degenhardt, Louisa, Clark, Brodie, Macpherson, Georgina, Leppan, Oscar, Nielsen, Suzanne, Zahra, Emma, Larance, Briony, Kimber, Jo, Martino-Burke, Daniel, Hickman, Matthew, Farrell, Michael (2023). Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies. The lancet. Psychiatry. https://doi.org/10.1016/s2215-0366(23)00095-0
  2. Furst, John A, Mynarski, Nicholas J, McCall, Kenneth L, Piper, Brian J (2022). Pronounced Regional Disparities in United States Methadone Distribution. The Annals of pharmacotherapy. https://doi.org/10.1177/10600280211028262
  3. Jiang, Xinyi, Guy, Gery P, Dever, Jill A, Richardson, John S, Dunlap, Laura J, Turcios, Didier, Wolicki, Sara Beth, Edlund, Mark J, Losby, Jan L (2025). Association Between Length of Buprenorphine or Methadone Use and Nonprescribed Opioid Use Among Individuals with Opioid Use Disorder: A Cohort Study. Substance use & addiction journal. https://doi.org/10.1177/29767342241266038
  4. Donny, Eric C, Walsh, Sharon L, Bigelow, George E, Eissenberg, Thomas, Stitzer, Maxine L (2002). High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans. Psychopharmacology. https://doi.org/10.1007/s00213-002-1027-0
  5. Pereira da Silva, Anderson Matheus, de Bastos Maximiano, Mariana Leticia, Cabeça, Lucas Silva, Leal Silva, Levi, Honorato de Faria, Elizabeth, Nepomuceno Fernandes, Matheus, Barros Mesquita Cunha, Ariane, Silva Vieira, Gabrielle, Duarte Ribeiro Sobral, Thierry, Vicente de Siqueira Lima Júnior, Daniel, Bernadete de Sousa Maia, Maria, de Souza Franco, Eryvelton (2025). Buprenorphine-naloxone vs methadone for opioid use disorder: a systematic review and meta-analysis of randomized clinical trials. Journal of addictive diseases. https://doi.org/10.1080/10550887.2025.2514308
  6. Morse, Eric, Christianson, Graeme, Olivadoti, Melissa, Timberlake, John (2024). Patient Challenges in Utilization of Methadone to Treat Opioid Use Disorder and Perspectives on a Solution for Improved Security and Convenience in Take-home Dosing. Innovations in clinical neuroscience.
  7. Gregory, Caroline, Yadav, Krishan, Linders, Jordyn, Sikora, Lindsey, Eagles, Debra (2025). Incidence of buprenorphine-precipitated opioid withdrawal in adults with opioid use disorder: A systematic review. Addiction (Abingdon, England). https://doi.org/10.1111/add.16646
  8. Braun, Hannan M, Taylor, Jessica L, Axelrath, Sarah (2024). Buprenorphine/naloxone – one formulation that doesn't fit all: a case report. Harm reduction journal. https://doi.org/10.1186/s12954-024-01054-2
  9. Comer, Sandra D, Sullivan, Maria A, Vosburg, Suzanne K, Manubay, Jeanne, Amass, Leslie, Cooper, Ziva D, Saccone, Phillip, Kleber, Herbert D (2010). Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusers. Addiction (Abingdon, England). https://doi.org/10.1111/j.1360-0443.2009.02843.x
  10. Jones, Christopher M, Shoff, Carla, Blanco, Carlos, Losby, Jan L, Ling, Shari M, Compton, Wilson M (2024). Overdose, Behavioral Health Services, and Medications for Opioid Use Disorder After a Nonfatal Overdose. JAMA internal medicine. https://doi.org/10.1001/jamainternmed.2024.1733
  11. Mattick, R P, Breen, C, Kimber, J, Davoli, M (2003). Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. The Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd002209
  12. Cope, Kevin, DeMicco, James, Salib, Justina, Michael, Mina, Yakoub, Peter, Daoud, Kirollos, Cope, Rebecca (2022). Three-year Retention Rates With Office-based Treatment of Buprenorphine for Opioid Use Disorder in a Private Family Medicine Practice. Journal of addiction medicine. https://doi.org/10.1097/adm.0000000000001009
  13. Sherrick, Robert C (2025). Relationship Between Methadone Induction Dosing and Retention in Treatment in Opioid Treatment Programs. Journal of addiction medicine. https://doi.org/10.1097/adm.0000000000001473
  14. Kawasaki, Sarah S, Zimmerman, Rachel, Shen, Chan, Zgierska, Aleksandra E (2023). COVID-19-related flexibility in methadone take-home doses associated with decreased attrition: Report from an opioid treatment program in central Pennsylvania. Journal of substance use and addiction treatment. https://doi.org/10.1016/j.josat.2023.209164
  15. Gloeck, N R, Harris, B N, Webb, E M, Scheibe, A (2020). Factors predicting 6-month retention among people with opioid use disorders accessing outpatient methadone maintenance therapy in Tshwane, South Africa. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde. https://doi.org/10.7196/samj.2020.v111i1.14884
  16. Barkhordari, Hoda, Masoumi, Mohammad, Moazenzadeh, Mansour, Esmaili, Hamidreza, Rashidinejad, Hamidreza (2025). Cardiac Assessment of Individuals with Opioid Use Disorder under Methadone Treatment. Journal of research in pharmacy practice. https://doi.org/10.4103/jrpp.jrpp_15_25
  17. Tjagvad, Christian, Skurtveit, Svetlana, Linnet, Kristian, Andersen, Ljubica Vukelic, Christoffersen, Dorte J, Clausen, Thomas (2016). Methadone-Related Overdose Deaths in a Liberal Opioid Maintenance Treatment Programme. European addiction research. https://doi.org/10.1159/000446429
  18. Zoorob, Roger, Kowalchuk, Alicia, Mejia de Grubb, Maria (2018). Buprenorphine Therapy for Opioid Use Disorder. American family physician.
  19. Thomas, Cindy Parks, Reif, Sharon, Haq, Sayeda, Wallack, Stanley S, Hoyt, Alexander, Ritter, Grant A (2008). Use of buprenorphine for addiction treatment: perspectives of addiction specialists and general psychiatrists. Psychiatric services (Washington, D.C.). https://doi.org/10.1176/ps.2008.59.8.909
  20. McHugh, R Kathryn, Bailey, Allen J, McConaghy, Brooke A, Weiss, Roger D, Fiellin, David A, Hillhouse, Maureen, Moore, Brent A, Fitzmaurice, Garrett M (2025). Behavioral Therapy as an Adjunct to Buprenorphine Treatment for Opioid Use Disorder: A Secondary Analysis of 4 Randomized Clinical Trials. JAMA Netw Open. https://doi.org/10.1001/jamanetworkopen.2025.28529
  21. Nasser, Azmi F, Heidbreder, Christian, Liu, Yongzhen, Fudala, Paul J (2015). Pharmacokinetics of Sublingual Buprenorphine and Naloxone in Subjects with Mild to Severe Hepatic Impairment (Child-Pugh Classes A, B, and C), in Hepatitis C Virus-Seropositive Subjects, and in Healthy Volunteers. Clinical pharmacokinetics. https://doi.org/10.1007/s40262-015-0238-6
Written by
Jessica Miller is the Content Manager of Addiction Help

Editorial Director

Jessica Miller is the Editorial Director of Addiction Help. Jessica graduated from the University of South Florida (USF) with an English degree and combines her writing expertise and passion for helping others to deliver reliable information to those impacted by addiction. Informed by her personal journey to recovery and support of loved ones in sobriety, Jessica's empathetic and authentic approach resonates deeply with the Addiction Help community.

Reviewed by
  • Fact-Checked
  • Editor
Kent S. Hoffman, D.O. is a founder of Addiction Help

Co-Founder & Chief Medical Officer

Kent S. Hoffman, D.O. has been an expert in addiction medicine for more than 15 years. In addition to managing a successful family medical practice, Dr. Hoffman is board certified in addiction medicine by the American Osteopathic Academy of Addiction Medicine (AOAAM). Dr. Hoffman has successfully treated hundreds of patients battling addiction. Dr. Hoffman is the Co-Founder and Chief Medical Officer of AddictionHelp.com and ensures the website’s medical content and messaging quality.

Real Help. Real Recovery.

Compare centers, explore options and start your path to recovery today.

Find Treatment Now

"AddictionHelp.com is helping to make recovery available to EVERYONE!"

- Angela N.